Product Information

OSELTAMIVIR 6 MG/ML SUSPENSION is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.1555 per ML under NDC 76282073952. Its NADAC has been published 136 times since Apr 10, 2024.

FDA first approved this application on Aug 30, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OSELTAMIVIR 6 MG/ML SUSPENSION

OSELTAMIVIR PHOSPHATE
$0.1555per ML

Strength

6 mg/mL

NDC

76282073952

Classification

Generic

Dosage Form

FOR SUSPENSION

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

OSELTAMIVIR PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212858

FDA Approved

8/30/2021

TE Code

AB

On Market Since

12/1/2023

Pharmacological Classes

Neuraminidase Inhibitor
Neuraminidase Inhibitors

Price Statistics

The NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has been published 136 times since Apr 10, 2024, and over the history we have for it it has declined 42.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1555 per ML
All-time high$0.2682 (Apr 10, 2024)
All-time low$0.1271 (Nov 20, 2024)
52-week high$0.1711
52-week low$0.1496
Median price$0.1738
Average price$0.1772
Largest weekly change+38.5% (Dec 18, 2024)
Weeks tracked136
Tracking sinceApr 10, 2024

Price History

1W

0.0%

1M

+3.9%

3M

+1.6%

6M

+0.4%

1Y

-6.1%

3Y

N/A

5Y

N/A

All

-42.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 2%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OSELTAMIVIR 6 MG/ML SUSPENSION?

The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR 6 MG/ML SUSPENSION, manufactured by Exelan Pharmaceuticals Inc., is $0.1555 per ML (NDC 76282073952), effective Nov 11, 2026.

How has the price of OSELTAMIVIR 6 MG/ML SUSPENSION changed over time?

Over the history we have for it, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has declined 42.0%. It has been tracked across 136 weekly CMS publications since Apr 10, 2024.

What are the highest and lowest recorded NADAC prices for OSELTAMIVIR 6 MG/ML SUSPENSION?

Since Apr 10, 2024, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has ranged from a low of $0.1271 (Nov 20, 2024) to a high of $0.2682 (Apr 10, 2024), with a median of $0.1738 per ML.

Are there cheaper alternatives to OSELTAMIVIR 6 MG/ML SUSPENSION?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OSELTAMIVIR 6 MG/ML SUSPENSION, is $0.1519 per ML — about 2% below OSELTAMIVIR 6 MG/ML SUSPENSION.

Who manufactures OSELTAMIVIR 6 MG/ML SUSPENSION?

OSELTAMIVIR 6 MG/ML SUSPENSION (NDC 76282073952) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.